Colitis, Ulcerative

23 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Colitis, Gastroenteritis, Inflammatory Bowel Diseases

Treatments and conditions

Colitis, Ulcerative
Treatment and conditionWhere it standsTrials
AC-101 for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Atorvastatin calcium trihydrate for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Bezlotoxumab for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Duvakitug for colitis, ulcerativePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Emvistegrast for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fecal Microbial Transplantation for colitis, ulcerativePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Golimumab for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Guselkumab for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
INT-210 Capsule for colitis, ulcerativePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
JNJ-78934804 for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Mirikizumab for colitis, ulcerativePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Obefazimod for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
PALI-2108 for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Phentermine-Topiramate for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo-to-match emvistegrast + Emvistegrast for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
single FMT for colitis, ulcerativePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
SPY001 for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
SPY001 + SPY002 for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
SPY001 + SPY003 for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
SPY002 for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
SPY002 + SPY003 for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
SPY003 for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Vedolizumab for colitis, ulcerativePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.